Cargando…
In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
Autores principales: | Fernandes, Guillaume, Devresse, Arnaud, Scohy, Anais, De Greef, Julien, Yombi, Jean Cyr, Belkhir, Leila, Darius, Tom, Mourad, Michel, Buemi, Antoine, Kabamba, Benoit, Goffin, Eric, Kanaan, Nada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222403/ https://www.ncbi.nlm.nih.gov/pubmed/35765465 http://dx.doi.org/10.1016/j.xkme.2022.100503 |
Ejemplares similares
-
Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series
por: Fernandes, Guillaume, et al.
Publicado: (2022) -
Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
por: De Greef, Julien, et al.
Publicado: (2021) -
COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium
por: Devresse, Arnaud, et al.
Publicado: (2020) -
High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
por: Georgery, Hélène, et al.
Publicado: (2021) -
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)